NFKB1 and renal fibrosis: Studies have confirmed that salidroside reduces excessive deposition of ECM, prevents epithelial cell EMT, and ameliorates renal fibrosis by inhibiting the expression of TLR4/MAPK/NF-κB signaling pathway and its downstream pro-inflammatory and pro-fibrotic factors [78].